Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients satisfaction: a cross-sectional survey by patient organisations
Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients satisfaction: a cross-sectional survey by patient organisations